BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38353039)

  • 1. The impact of race and other demographic factors on the false positive rates of five embedded Performance Validity Tests (PVTs) in a Veteran sample.
    Denning JH; Horner MD
    J Clin Exp Neuropsychol; 2024 Feb; 46(1):25-35. PubMed ID: 38353039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demographic differences in performance validity test failure.
    Braun SE; Fountain-Zaragoza S; Halliday CA; Horner MD
    Appl Neuropsychol Adult; 2023; 30(5):483-491. PubMed ID: 34428386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of Embedded Performance Validity Tests in Elderly Veterans with Mild and Major Neurocognitive Disorder.
    Kanser RJ; Logan PM; Steward KA; Vanderbleek EN; Kamper JE
    Arch Clin Neuropsychol; 2023 Jul; 38(5):772-781. PubMed ID: 36578198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When 10 is enough: Errors on the first 10 items of the Test of Memory Malingering (TOMMe10) and administration time predict freestanding performance validity tests (PVTs) and underperformance on memory measures.
    Denning JH
    Appl Neuropsychol Adult; 2021; 28(1):35-47. PubMed ID: 30950290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-validation of the Trail Making Test as a non-memory-based embedded performance validity test among veterans with and without cognitive impairment.
    Peak AM; Marceaux JC; Chicota-Carroll C; Soble JR
    J Clin Exp Neuropsychol; 2024 Feb; 46(1):16-24. PubMed ID: 38007610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivariable analysis of the relative utility and additive value of eight embedded performance validity tests for classifying invalid neuropsychological test performance.
    Jennette KJ; Rhoads T; Resch ZJ; Cerny BM; Leib SI; Sharp DW; Ovsiew GP; Soble JR
    J Clin Exp Neuropsychol; 2022 Sep; 44(7):451-460. PubMed ID: 36197342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examination of optimal embedded PVTs within the BVMT-R in an outpatient clinical sample.
    Olsen DH; Schroeder RW; Heinrichs RJ; Martin PK
    Clin Neuropsychol; 2019 May; 33(4):732-742. PubMed ID: 30354925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Not so fast! Limitations of processing speed and working memory indices as embedded performance validity tests in a mixed neuropsychiatric sample.
    Ovsiew GP; Resch ZJ; Nayar K; Williams CP; Soble JR
    J Clin Exp Neuropsychol; 2020 Jul; 42(5):473-484. PubMed ID: 32498648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial differences in positive findings on embedded performance validity tests.
    Hromas G; Rolin S; Davis JJ
    Appl Neuropsychol Adult; 2022 Nov; ():1-9. PubMed ID: 36416227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-validation of non-memory-based embedded performance validity tests for detecting invalid performance among patients with and without neurocognitive impairment.
    White DJ; Korinek D; Bernstein MT; Ovsiew GP; Resch ZJ; Soble JR
    J Clin Exp Neuropsychol; 2020 Jul; 42(5):459-472. PubMed ID: 32397824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embedded performance validity tests within the Hopkins Verbal Learning Test - Revised and the Brief Visuospatial Memory Test - Revised.
    Sawyer RJ; Testa SM; Dux M
    Clin Neuropsychol; 2017 Jan; 31(1):207-218. PubMed ID: 27758163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the Psychometric Properties of Eight Embedded Performance Validity Tests in the Rey Auditory Verbal Learning Test, Wechsler Memory Scale Logical Memory, and Brief Visuospatial Memory Test-Revised Recognition Trials for Detecting Invalid Neuropsychological Test Performance.
    Pliskin JI; DeDios Stern S; Resch ZJ; Saladino KF; Ovsiew GP; Carter DA; Soble JR
    Assessment; 2021 Dec; 28(8):1871-1881. PubMed ID: 32484371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychometric implications of failure on one performance validity test: a cross-validation study to inform criterion group definition.
    Rhoads T; Neale AC; Resch ZJ; Cohen CD; Keezer RD; Cerny BM; Jennette KJ; Ovsiew GP; Soble JR
    J Clin Exp Neuropsychol; 2021 Jul; 43(5):437-448. PubMed ID: 34233580
    [No Abstract]   [Full Text] [Related]  

  • 14. CVLT-II Forced Choice Recognition Trial as an Embedded Validity Indicator: A Systematic Review of the Evidence.
    Schwartz ES; Erdodi L; Rodriguez N; Ghosh JJ; Curtain JR; Flashman LA; Roth RM
    J Int Neuropsychol Soc; 2016 Sep; 22(8):851-8. PubMed ID: 27619108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Convergent, Discriminant, and Concurrent Validity of Nonmemory-Based Performance Validity Tests.
    Webber TA; Critchfield EA; Soble JR
    Assessment; 2020 Oct; 27(7):1399-1415. PubMed ID: 30293445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are there differences in performance validity test scores between African American and White American neuropsychology clinic patients?
    D Hood E; B Boone K; S Miora D; E Cottingham M; L Victor T; A Zeigler E; A Zeller M; J Wright M
    J Clin Exp Neuropsychol; 2022 Feb; 44(1):31-41. PubMed ID: 35670549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of various WAIS-IV Digit Span indices for identifying noncredible performance validity among cognitively impaired and unimpaired examinees.
    Webber TA; Soble JR
    Clin Neuropsychol; 2018 May; 32(4):657-670. PubMed ID: 29256334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embedded Performance Validity Tests in the Hopkins Verbal Learning Test-Revised and the Brief Visuospatial Memory Test-Revised: A Replication Study.
    Bailey KC; Soble JR; Bain KM; Fullen C
    Arch Clin Neuropsychol; 2018 Nov; 33(7):895-900. PubMed ID: 29161350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment does not cause invalid performance: analyzing performance patterns among cognitively unimpaired, impaired, and noncredible participants across six performance validity tests.
    Critchfield E; Soble JR; Marceaux JC; Bain KM; Chase Bailey K; Webber TA; Alex Alverson W; Messerly J; Andrés González D; O'Rourke JJF
    Clin Neuropsychol; 2019 Aug; 33(6):1083-1101. PubMed ID: 30475095
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluating the Medical Symptom Validity Test (MSVT) in a Sample of Veterans Between the Ages of 18 to 64.
    Reslan S; Axelrod BN
    Appl Neuropsychol Adult; 2017; 24(2):132-139. PubMed ID: 27045467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.